Seelos Therapeutics Total Assets 2010-2022 | SEEL

Seelos Therapeutics total assets from 2010 to 2022. Total assets can be defined as the sum of all assets on a company's balance sheet.
Seelos Therapeutics Annual Total Assets
(Millions of US $)
2021 $84
2020 $17
2019 $11
2018 $0
2017 $7
2016 $5
2015 $8
2014 $15
2013 $23
2012 $24
2011 $17
2010 $19
2009 $21
Seelos Therapeutics Quarterly Total Assets
(Millions of US $)
2022-09-30 $41
2022-06-30 $53
2022-03-31 $71
2021-12-31 $84
2021-09-30 $81
2021-06-30 $90
2021-03-31 $41
2020-12-31 $17
2020-09-30 $10
2020-06-30 $8
2020-03-31 $14
2019-12-31 $11
2019-09-30 $16
2019-06-30 $10
2019-03-31 $12
2018-12-31 $0
2018-09-30 $6
2018-06-30 $7
2018-03-31 $6
2017-12-31 $7
2017-09-30 $9
2017-06-30 $9
2017-03-31 $5
2016-12-31 $5
2016-09-30 $8
2016-06-30 $6
2016-03-31 $10
2015-12-31 $8
2015-09-30 $10
2015-06-30 $11
2015-03-31 $20
2014-12-31 $15
2014-09-30 $20
2014-06-30 $20
2014-03-31 $25
2013-12-31 $23
2013-09-30 $22
2013-06-30 $27
2013-03-31 $17
2012-12-31 $24
2012-09-30 $41
2012-06-30 $29
2012-03-31 $32
2011-12-31 $17
2011-09-30 $14
2011-06-30 $14
2011-03-31 $20
2010-12-31 $19
2010-09-30 $0
2010-06-30 $24
2010-03-31 $22
2009-12-31 $21
2009-09-30 $7
2009-06-30 $8
2009-03-31 $9
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.092B $0.000B
Seelos Therapeutics Inc. is a clinical-stage biopharmaceutical company. It focused on the development and advancement of novel therapeutics to address unmet medical needs for central nervous system disorders. The company's product pipeline consists of SLS-002, SLS-006, SLS-008, SLS-010 and SLS-012 which are in clinical stage. Seelos Therapeutics Inc., formerly known as Apricus Biosciences Inc., is based in New York, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $158.441B 9.68
GSK (GSK) United Kingdom $74.044B 9.78
Bio-Rad Laboratories (BIO.B) United States $12.069B 28.64
QIAGEN (QGEN) Netherlands $11.308B 21.01
Ginkgo Bioworks Holdings (DNA) United States $3.880B 0.00
Myovant Sciences (MYOV) United Kingdom $2.617B 0.00
Arcus Biosciences (RCUS) United States $1.545B 23.20
Biohaven (BHVN) United States $1.265B 0.00
Emergent Biosolutions (EBS) United States $0.703B 5.53
ADC Therapeutics SA (ADCT) Switzerland $0.348B 0.00
Enzo Biochem (ENZ) United States $0.068B 0.00
Ambrx Biopharma (AMAM) United States $0.066B 0.00
Gelesis Holdings (GLS) United States $0.025B 0.00
SQZ Biotechnologies (SQZ) United States $0.024B 0.00